APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Drug and Medical Device Testing Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Drug and Medical Device Testing Services Market Analysis and Forecast 2026-2032

Report ID 17412304024 March 2026196 pages

Choose your research edition.

Industry ResearchDrug and Medical Device Testing Services Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug and Medical Device Testing Services Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Drug and Medical Device Testing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug and Medical Device Testing Services Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug and Medical Device Testing Services Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Drug and Medical Device Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Drug and Medical Device Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Drug and Medical Device Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Drug and Medical Device Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Drug and Medical Device Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Drug and Medical Device Testing Services include SGS, Intertek, Eurofins, Bureau Veritas, TÜV SÜD, DEKRA, UL, TÜV Rheinland and NAMSA, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Drug and Medical Device Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Drug and Medical Device Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Drug and Medical Device Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Drug and Medical Device Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Drug and Medical Device Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Drug and Medical Device Testing Services revenue, projected growth trends, production technology, application and end-user industry.

Drug and Medical Device Testing Services Segment by Company

SGS

Intertek

Eurofins

Bureau Veritas

TÜV SÜD

DEKRA

UL

TÜV Rheinland

NAMSA

BSI Group

Jiangsu Bioperfectus Technologies Co.,Ltd.

SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.

Henan Zhongmei Technical Inspection Service Co.

Wuxi New Drug Development Co., Ltd. Shanghai

Drug and Medical Device Testing Services Segment by Type

Drug Testing

Medical Device Testing

Drug and Medical Device Testing Services Segment by Application

Pharmaceutical

Medical Instruments

Drug R&D and Clinical Trials

Others

Drug and Medical Device Testing Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug and Medical Device Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug and Medical Device Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug and Medical Device Testing Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Drug and Medical Device Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Drug and Medical Device Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug and Medical Device Testing Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug and Medical Device Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Drug Testing Major Player Table 3. Medical Device Testing Major Player Table 4. Global Drug and Medical Device Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Major Player Table 6. Medical Instruments Major Player Table 7. Drug R&D and Clinical Trials Major Player Table 8. Others Major Player Table 9. Drug and Medical Device Testing Services Industry Trends Table 10. Drug and Medical Device Testing Services Industry Drivers Table 11. Drug and Medical Device Testing Services Industry Opportunities and Challenges Table 12. Drug and Medical Device Testing Services Industry Restraints Table 13. Global Drug and Medical Device Testing Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Drug and Medical Device Testing Services Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Drug and Medical Device Testing Services Market Share by Region (2021-2026) Table 16. Global Drug and Medical Device Testing Services Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Drug and Medical Device Testing Services Market Share by Region (2027-2032) Table 18. Global Drug and Medical Device Testing Services Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Drug and Medical Device Testing Services Revenue Market Share by Players (2021-2026) Table 20. Global Drug and Medical Device Testing Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Drug and Medical Device Testing Services Key Players Headquarters & Area Served Table 22. Global Drug and Medical Device Testing Services Players, Product Type & Application Table 23. Global Drug and Medical Device Testing Services Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Drug and Medical Device Testing Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Drug and Medical Device Testing Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug and Medical Device Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Drug and Medical Device Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Drug and Medical Device Testing Services Revenue Market Share by Type (2021-2026) Table 30. Global Drug and Medical Device Testing Services Revenue Market Share by Type (2027-2032) Table 31. Global Drug and Medical Device Testing Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug and Medical Device Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Drug and Medical Device Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Drug and Medical Device Testing Services Revenue Market Share by Application (2021-2026) Table 35. Global Drug and Medical Device Testing Services Revenue Market Share by Application (2027-2032) Table 36. SGS Company Information Table 37. SGS Business Overview Table 38. SGS Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. SGS Drug and Medical Device Testing Services Product Portfolio Table 40. SGS Recent Development Table 41. Intertek Company Information Table 42. Intertek Business Overview Table 43. Intertek Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Intertek Drug and Medical Device Testing Services Product Portfolio Table 45. Intertek Recent Development Table 46. Eurofins Company Information Table 47. Eurofins Business Overview Table 48. Eurofins Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Eurofins Drug and Medical Device Testing Services Product Portfolio Table 50. Eurofins Recent Development Table 51. Bureau Veritas Company Information Table 52. Bureau Veritas Business Overview Table 53. Bureau Veritas Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Bureau Veritas Drug and Medical Device Testing Services Product Portfolio Table 55. Bureau Veritas Recent Development Table 56. TÜV SÜD Company Information Table 57. TÜV SÜD Business Overview Table 58. TÜV SÜD Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. TÜV SÜD Drug and Medical Device Testing Services Product Portfolio Table 60. TÜV SÜD Recent Development Table 61. DEKRA Company Information Table 62. DEKRA Business Overview Table 63. DEKRA Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. DEKRA Drug and Medical Device Testing Services Product Portfolio Table 65. DEKRA Recent Development Table 66. UL Company Information Table 67. UL Business Overview Table 68. UL Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. UL Drug and Medical Device Testing Services Product Portfolio Table 70. UL Recent Development Table 71. TÜV Rheinland Company Information Table 72. TÜV Rheinland Business Overview Table 73. TÜV Rheinland Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. TÜV Rheinland Drug and Medical Device Testing Services Product Portfolio Table 75. TÜV Rheinland Recent Development Table 76. NAMSA Company Information Table 77. NAMSA Business Overview Table 78. NAMSA Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. NAMSA Drug and Medical Device Testing Services Product Portfolio Table 80. NAMSA Recent Development Table 81. BSI Group Company Information Table 82. BSI Group Business Overview Table 83. BSI Group Drug and Medical Device Testing Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. BSI Group Drug and Medical Device Testing Services Product Portfolio Table 85. BSI Group Recent Development Table 86. Jiangsu Bioperfectus Technologies Co.,Ltd. Company Information Table 87. Jiangsu Bioperfectus Technologies Co.,Ltd. Business Overview Table 88. Jiangsu Bioperfectus Technologies Co.,Ltd. Drug and Medical Device Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Jiangsu Bioperfectus Technologies Co.,Ltd. Drug and Medical Device Testing Services Product Portfolio Table 90. Jiangsu Bioperfectus Technologies Co.,Ltd. Recent Development Table 91. SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Company Information Table 92. SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Business Overview Table 93. SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Drug and Medical Device Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Drug and Medical Device Testing Services Product Portfolio Table 95. SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Recent Development Table 96. Henan Zhongmei Technical Inspection Service Co. Company Information Table 97. Henan Zhongmei Technical Inspection Service Co. Business Overview Table 98. Henan Zhongmei Technical Inspection Service Co. Drug and Medical Device Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Henan Zhongmei Technical Inspection Service Co. Drug and Medical Device Testing Services Product Portfolio Table 100. Henan Zhongmei Technical Inspection Service Co. Recent Development Table 101. Wuxi New Drug Development Co., Ltd. Shanghai Company Information Table 102. Wuxi New Drug Development Co., Ltd. Shanghai Business Overview Table 103. Wuxi New Drug Development Co., Ltd. Shanghai Drug and Medical Device Testing Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Wuxi New Drug Development Co., Ltd. Shanghai Drug and Medical Device Testing Services Product Portfolio Table 105. Wuxi New Drug Development Co., Ltd. Shanghai Recent Development Table 106. North America Drug and Medical Device Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 107. North America Drug and Medical Device Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 108. North America Drug and Medical Device Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Drug and Medical Device Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Drug and Medical Device Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Drug and Medical Device Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 112. North America Drug and Medical Device Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 113. Europe Drug and Medical Device Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe Drug and Medical Device Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe Drug and Medical Device Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe Drug and Medical Device Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe Drug and Medical Device Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe Drug and Medical Device Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 119. Europe Drug and Medical Device Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 120. China Drug and Medical Device Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 121. China Drug and Medical Device Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 122. China Drug and Medical Device Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 123. China Drug and Medical Device Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Drug and Medical Device Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 125. Asia Drug and Medical Device Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 126. Asia Drug and Medical Device Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia Drug and Medical Device Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia Drug and Medical Device Testing Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia Drug and Medical Device Testing Services Revenue by Region (US$ Million) & (2021-2026) Table 130. Asia Drug and Medical Device Testing Services Revenue by Region (US$ Million) & (2027-2032) Table 131. SAMEA Drug and Medical Device Testing Services Revenue by Type (2021-2026) & (US$ Million) Table 132. SAMEA Drug and Medical Device Testing Services Revenue by Type (2027-2032) & (US$ Million) Table 133. SAMEA Drug and Medical Device Testing Services Revenue by Application (2021-2026) & (US$ Million) Table 134. SAMEA Drug and Medical Device Testing Services Revenue by Application (2027-2032) & (US$ Million) Table 135. SAMEA Drug and Medical Device Testing Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. SAMEA Drug and Medical Device Testing Services Revenue by Country (2021-2026) & (US$ Million) Table 137. SAMEA Drug and Medical Device Testing Services Revenue by Country (US$ Million) & (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Drug and Medical Device Testing Services Image Figure 2. Global Drug and Medical Device Testing Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drug and Medical Device Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Drug Testing Image Figure 5. Medical Device Testing Image Figure 6. Global Drug and Medical Device Testing Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Drug and Medical Device Testing Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Image Figure 9. Medical Instruments Image Figure 10. Drug R&D and Clinical Trials Image Figure 11. Others Image Figure 12. Global Drug and Medical Device Testing Services Market Size (US$ Million) & (2021-2032) Figure 13. Global Drug and Medical Device Testing Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Drug and Medical Device Testing Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Drug and Medical Device Testing Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Drug and Medical Device Testing Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Drug and Medical Device Testing Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Drug and Medical Device Testing Services Revenue Market Share by Type (2021-2032) Figure 20. Global Drug and Medical Device Testing Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Drug and Medical Device Testing Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Drug and Medical Device Testing Services Revenue Market Share by Application (2021-2032) Figure 23. North America Drug and Medical Device Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Drug and Medical Device Testing Services Revenue Share by Type (2021-2032) Figure 25. North America Drug and Medical Device Testing Services Revenue Share by Application (2021-2032) Figure 26. North America Drug and Medical Device Testing Services Revenue Share by Country (2021-2032) Figure 27. United States Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Drug and Medical Device Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Drug and Medical Device Testing Services Revenue Share by Type (2021-2032) Figure 32. Europe Drug and Medical Device Testing Services Revenue Share by Application (2021-2032) Figure 33. Europe Drug and Medical Device Testing Services Revenue Share by Country (2021-2032) Figure 34. Germany Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Drug and Medical Device Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Drug and Medical Device Testing Services Revenue Share by Type (2021-2032) Figure 44. China Drug and Medical Device Testing Services Revenue Share by Application (2021-2032) Figure 45. Asia Drug and Medical Device Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Drug and Medical Device Testing Services Revenue Share by Type (2021-2032) Figure 47. Asia Drug and Medical Device Testing Services Revenue Share by Application (2021-2032) Figure 48. Asia Drug and Medical Device Testing Services Revenue Share by Region (2021-2032) Figure 49. Japan Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Drug and Medical Device Testing Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Drug and Medical Device Testing Services Revenue Share by Type (2021-2032) Figure 57. SAMEA Drug and Medical Device Testing Services Revenue Share by Application (2021-2032) Figure 58. SAMEA Drug and Medical Device Testing Services Revenue Share by Country (2021-2032) Figure 59. Brazil Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Drug and Medical Device Testing Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Drug Testing
  • Medical Device Testing
Applications
  • Pharmaceutical
  • Medical Instruments
  • Drug R&D and Clinical Trials
  • Others
Companies covered
  • SGS
  • Intertek
  • Eurofins
  • Bureau Veritas
  • TÜV SÜD
  • DEKRA
  • UL
  • TÜV Rheinland
  • NAMSA
  • BSI Group
  • Jiangsu Bioperfectus Technologies Co.,Ltd.
  • SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
  • Henan Zhongmei Technical Inspection Service Co.
  • Wuxi New Drug Development Co., Ltd. Shanghai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Drug and Medical Device Testing Services Market by Type
  3. 1.2.1 Global Drug and Medical Device Testing Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Drug Testing
  5. 1.2.3 Medical Device Testing
  6. 1.3 Drug and Medical Device Testing Services Market by Application
  7. 1.3.1 Global Drug and Medical Device Testing Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical
  9. 1.3.3 Medical Instruments
  10. 1.3.4 Drug R&D and Clinical Trials
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Drug and Medical Device Testing Services Market Dynamics
  1. 2.1 Drug and Medical Device Testing Services Industry Trends
  2. 2.2 Drug and Medical Device Testing Services Industry Drivers
  3. 2.3 Drug and Medical Device Testing Services Industry Opportunities and Challenges
  4. 2.4 Drug and Medical Device Testing Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Drug and Medical Device Testing Services Market Perspective (2021-2032)
  2. 3.2 Global Drug and Medical Device Testing Services Growth Trends by Region
  3. 3.2.1 Global Drug and Medical Device Testing Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Drug and Medical Device Testing Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Drug and Medical Device Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Drug and Medical Device Testing Services Revenue by Players
  2. 4.1.1 Global Drug and Medical Device Testing Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Drug and Medical Device Testing Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Drug and Medical Device Testing Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Drug and Medical Device Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Drug and Medical Device Testing Services Key Players Headquarters & Area Served
  7. 4.4 Global Drug and Medical Device Testing Services Players, Product Type & Application
  8. 4.5 Global Drug and Medical Device Testing Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Drug and Medical Device Testing Services Market CR5 and HHI
  11. 4.6.3 2025 Drug and Medical Device Testing Services Tier 1, Tier 2, and Tier 3
5 Drug and Medical Device Testing Services Market Size by Type
  1. 5.1 Global Drug and Medical Device Testing Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug and Medical Device Testing Services Revenue by Type (2021-2032)
  3. 5.3 Global Drug and Medical Device Testing Services Revenue Market Share by Type (2021-2032)
6 Drug and Medical Device Testing Services Market Size by Application
  1. 6.1 Global Drug and Medical Device Testing Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Drug and Medical Device Testing Services Revenue by Application (2021-2032)
  3. 6.3 Global Drug and Medical Device Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SGS
  2. 7.1.1 SGS Company Information
  3. 7.1.2 SGS Business Overview
  4. 7.1.3 SGS Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SGS Drug and Medical Device Testing Services Product Portfolio
  6. 7.1.5 SGS Recent Developments
  7. 7.2 Intertek
  8. 7.2.1 Intertek Company Information
  9. 7.2.2 Intertek Business Overview
  10. 7.2.3 Intertek Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Intertek Drug and Medical Device Testing Services Product Portfolio
  12. 7.2.5 Intertek Recent Developments
  13. 7.3 Eurofins
  14. 7.3.1 Eurofins Company Information
  15. 7.3.2 Eurofins Business Overview
  16. 7.3.3 Eurofins Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Eurofins Drug and Medical Device Testing Services Product Portfolio
  18. 7.3.5 Eurofins Recent Developments
  19. 7.4 Bureau Veritas
  20. 7.4.1 Bureau Veritas Company Information
  21. 7.4.2 Bureau Veritas Business Overview
  22. 7.4.3 Bureau Veritas Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Bureau Veritas Drug and Medical Device Testing Services Product Portfolio
  24. 7.4.5 Bureau Veritas Recent Developments
  25. 7.5 TÜV SÜD
  26. 7.5.1 TÜV SÜD Company Information
  27. 7.5.2 TÜV SÜD Business Overview
  28. 7.5.3 TÜV SÜD Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 TÜV SÜD Drug and Medical Device Testing Services Product Portfolio
  30. 7.5.5 TÜV SÜD Recent Developments
  31. 7.6 DEKRA
  32. 7.6.1 DEKRA Company Information
  33. 7.6.2 DEKRA Business Overview
  34. 7.6.3 DEKRA Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 DEKRA Drug and Medical Device Testing Services Product Portfolio
  36. 7.6.5 DEKRA Recent Developments
  37. 7.7 UL
  38. 7.7.1 UL Company Information
  39. 7.7.2 UL Business Overview
  40. 7.7.3 UL Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 UL Drug and Medical Device Testing Services Product Portfolio
  42. 7.7.5 UL Recent Developments
  43. 7.8 TÜV Rheinland
  44. 7.8.1 TÜV Rheinland Company Information
  45. 7.8.2 TÜV Rheinland Business Overview
  46. 7.8.3 TÜV Rheinland Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 TÜV Rheinland Drug and Medical Device Testing Services Product Portfolio
  48. 7.8.5 TÜV Rheinland Recent Developments
  49. 7.9 NAMSA
  50. 7.9.1 NAMSA Company Information
  51. 7.9.2 NAMSA Business Overview
  52. 7.9.3 NAMSA Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 NAMSA Drug and Medical Device Testing Services Product Portfolio
  54. 7.9.5 NAMSA Recent Developments
  55. 7.10 BSI Group
  56. 7.10.1 BSI Group Company Information
  57. 7.10.2 BSI Group Business Overview
  58. 7.10.3 BSI Group Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 BSI Group Drug and Medical Device Testing Services Product Portfolio
  60. 7.10.5 BSI Group Recent Developments
  61. 7.11 Jiangsu Bioperfectus Technologies Co.,Ltd.
  62. 7.11.1 Jiangsu Bioperfectus Technologies Co.,Ltd. Company Information
  63. 7.11.2 Jiangsu Bioperfectus Technologies Co.,Ltd. Business Overview
  64. 7.11.3 Jiangsu Bioperfectus Technologies Co.,Ltd. Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Jiangsu Bioperfectus Technologies Co.,Ltd. Drug and Medical Device Testing Services Product Portfolio
  66. 7.11.5 Jiangsu Bioperfectus Technologies Co.,Ltd. Recent Developments
  67. 7.12 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co.
  68. 7.12.1 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Company Information
  69. 7.12.2 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Business Overview
  70. 7.12.3 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Drug and Medical Device Testing Services Product Portfolio
  72. 7.12.5 SGS (Qingdao) Testing Technology Co.SGS (Qingdao) Testing Technology Co. Recent Developments
  73. 7.13 Henan Zhongmei Technical Inspection Service Co.
  74. 7.13.1 Henan Zhongmei Technical Inspection Service Co. Company Information
  75. 7.13.2 Henan Zhongmei Technical Inspection Service Co. Business Overview
  76. 7.13.3 Henan Zhongmei Technical Inspection Service Co. Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Henan Zhongmei Technical Inspection Service Co. Drug and Medical Device Testing Services Product Portfolio
  78. 7.13.5 Henan Zhongmei Technical Inspection Service Co. Recent Developments
  79. 7.14 Wuxi New Drug Development Co., Ltd. Shanghai
  80. 7.14.1 Wuxi New Drug Development Co., Ltd. Shanghai Company Information
  81. 7.14.2 Wuxi New Drug Development Co., Ltd. Shanghai Business Overview
  82. 7.14.3 Wuxi New Drug Development Co., Ltd. Shanghai Drug and Medical Device Testing Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Wuxi New Drug Development Co., Ltd. Shanghai Drug and Medical Device Testing Services Product Portfolio
  84. 7.14.5 Wuxi New Drug Development Co., Ltd. Shanghai Recent Developments
8 North America
  1. 8.1 North America Drug and Medical Device Testing Services Revenue (2021-2032)
  2. 8.2 North America Drug and Medical Device Testing Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Drug and Medical Device Testing Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Drug and Medical Device Testing Services Revenue by Type (2027-2032)
  5. 8.3 North America Drug and Medical Device Testing Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Drug and Medical Device Testing Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Drug and Medical Device Testing Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Drug and Medical Device Testing Services Revenue by Application (2027-2032)
  9. 8.5 North America Drug and Medical Device Testing Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Drug and Medical Device Testing Services Revenue by Country
  11. 8.6.1 North America Drug and Medical Device Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Drug and Medical Device Testing Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Drug and Medical Device Testing Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Drug and Medical Device Testing Services Revenue (2021-2032)
  2. 9.2 Europe Drug and Medical Device Testing Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Drug and Medical Device Testing Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Drug and Medical Device Testing Services Revenue by Type (2027-2032)
  5. 9.3 Europe Drug and Medical Device Testing Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Drug and Medical Device Testing Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Drug and Medical Device Testing Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Drug and Medical Device Testing Services Revenue by Application (2027-2032)
  9. 9.5 Europe Drug and Medical Device Testing Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Drug and Medical Device Testing Services Revenue by Country
  11. 9.6.1 Europe Drug and Medical Device Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Drug and Medical Device Testing Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Drug and Medical Device Testing Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Drug and Medical Device Testing Services Revenue (2021-2032)
  2. 10.2 China Drug and Medical Device Testing Services Revenue by Type (2021-2032)
  3. 10.2.1 China Drug and Medical Device Testing Services Revenue by Type (2021-2026)
  4. 10.2.2 China Drug and Medical Device Testing Services Revenue by Type (2027-2032)
  5. 10.3 China Drug and Medical Device Testing Services Revenue Share by Type (2021-2032)
  6. 10.4 China Drug and Medical Device Testing Services Revenue by Application (2021-2032)
  7. 10.4.1 China Drug and Medical Device Testing Services Revenue by Application (2021-2026)
  8. 10.4.2 China Drug and Medical Device Testing Services Revenue by Application (2027-2032)
  9. 10.5 China Drug and Medical Device Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Drug and Medical Device Testing Services Revenue (2021-2032)
  2. 11.2 Asia Drug and Medical Device Testing Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Drug and Medical Device Testing Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Drug and Medical Device Testing Services Revenue by Type (2027-2032)
  5. 11.3 Asia Drug and Medical Device Testing Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Drug and Medical Device Testing Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Drug and Medical Device Testing Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Drug and Medical Device Testing Services Revenue by Application (2027-2032)
  9. 11.5 Asia Drug and Medical Device Testing Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Drug and Medical Device Testing Services Revenue by Country
  11. 11.6.1 Asia Drug and Medical Device Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Drug and Medical Device Testing Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Drug and Medical Device Testing Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Drug and Medical Device Testing Services Revenue (2021-2032)
  2. 12.2 SAMEA Drug and Medical Device Testing Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Drug and Medical Device Testing Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Drug and Medical Device Testing Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Drug and Medical Device Testing Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Drug and Medical Device Testing Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Drug and Medical Device Testing Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Drug and Medical Device Testing Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Drug and Medical Device Testing Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Drug and Medical Device Testing Services Revenue by Country
  11. 12.6.1 SAMEA Drug and Medical Device Testing Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Drug and Medical Device Testing Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Drug and Medical Device Testing Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst